Why the study?
Regional control of fibrosis after myocardial infarction is critical, but complex signaling pathway crosstalk confounds therapies for regional scar formation.
A computational model of cardiac fibroblast signaling identified potential mechano-adaptive drug targets that could regionally control fibrosis post-myocardial infarction based on local tissue tension.
Model of fibroblast signaling may guide regional post-MI fibrosis therapies; leaves open need for experimental validation.
Summary Regional control of fibrosis after myocardial infarction is critical for maintaining structural integrity in the infarct while preventing collagen accumulation in non-infarcted areas. Cardiac fibroblasts modulate matrix turnover in response to biochemical and biomechanical cues, but the complex interactions between signaling pathways confounds efforts to develop therapies for regional scar formation. Here, we employed a logic-based ordinary differential equation model of fibroblast mechano-chemo signal transduction to predict matrix protein expression in response to canonical biochemical stimuli and mechanical tension. Functional analysis of mechano-chemo interactions showed extensive pathway crosstalk with tension amplifying, dampening, or reversing responses to biochemical stimuli. Comprehensive drug target screens in low- and high-tension contexts identified 13 mechano-adaptive therapies that promote matrix accumulation in regions where it is needed and reduce matrix levels in regions where it is not needed. Our predictions demonstrate this approach’s utility for discovering context-specific mechanisms mediating fibrosis and druggable targets for spatially resolved therapies.
No takes yet. Share an insight, caveat, or question.
Rogers et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: